14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.65 $2.10 Wednesday, 1st May 2024 SONN stock ended at $1.86. This is 5.08% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.61% from a day low at $1.74 to a day high of $1.89.
90 days $1.31 $2.34
52 weeks $0.190 $4.80

Historical Sonnet Biotherapeutics Holdings Inc. prices

Date Open High Low Close Volume
May 01, 2024 $1.74 $1.89 $1.74 $1.86 31 234
Apr 30, 2024 $1.77 $1.78 $1.73 $1.77 7 077
Apr 29, 2024 $1.78 $1.78 $1.75 $1.78 7 268
Apr 26, 2024 $1.77 $1.80 $1.73 $1.77 9 532
Apr 25, 2024 $1.79 $1.79 $1.72 $1.76 4 826
Apr 24, 2024 $1.79 $1.85 $1.75 $1.85 6 161
Apr 23, 2024 $1.71 $1.84 $1.66 $1.78 18 191
Apr 22, 2024 $1.77 $1.78 $1.69 $1.70 17 711
Apr 19, 2024 $1.79 $1.89 $1.77 $1.82 21 973
Apr 18, 2024 $1.71 $1.78 $1.71 $1.77 17 032
Apr 17, 2024 $1.72 $1.73 $1.70 $1.70 9 932
Apr 16, 2024 $1.80 $1.87 $1.65 $1.67 28 032
Apr 15, 2024 $2.01 $2.01 $1.80 $1.81 45 868
Apr 12, 2024 $2.08 $2.08 $1.99 $2.00 18 830
Apr 11, 2024 $1.97 $2.10 $1.97 $2.02 27 768
Apr 10, 2024 $1.96 $2.00 $1.94 $1.97 8 967
Apr 09, 2024 $2.10 $2.10 $1.96 $1.96 24 821
Apr 08, 2024 $2.05 $2.08 $1.99 $2.03 24 935
Apr 05, 2024 $1.96 $2.06 $1.96 $2.00 18 734
Apr 04, 2024 $1.99 $2.03 $1.91 $1.98 18 515
Apr 03, 2024 $1.90 $2.00 $1.88 $1.96 21 388
Apr 02, 2024 $1.95 $1.98 $1.83 $1.90 49 737
Apr 01, 2024 $1.97 $2.03 $1.89 $1.89 19 018
Mar 28, 2024 $1.97 $1.97 $1.80 $1.86 70 343
Mar 27, 2024 $1.95 $2.03 $1.91 $2.03 39 338
Click to get the best stock tips daily for free!

About Sonnet Biotherapeutics Holdings Inc.

Sonnet Biotherapeutics Holdings. Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the ... SONN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT